Special Issue "Graphene-Based Materials for Cancer Therapy"
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: 15 July 2020.
Interests: Organic Synthesis; Advanced synthetic methodologies for the organic functionalization of nanomaterials for applications in drug delivery, biosensors, tissue engineering and in environmental field.
Interests: nanomaterials; drug delivery systems; tissue engineering; biomaterials
Special Issues and Collections in MDPI journals
Graphene-based nanomaterials such as fullerenes, carbon nanotubes graphene oxide, and graphene quantum dots have shown great potential in revolutionizing the future of nanomedicine and biotechnology. Their outstanding physical and chemical properties and the presence of more reactive groups on the graphene surface, which allow the multimodal conjugation with different functional groups and biologically active molecules, make them ideal candidates for cancer diagnosis and treatment. These nanomaterials have been conjugated with drugs and also labeled with tumor-targeting ligands, which are able to specifically recognize cancer receptors exposed on cancer cells, thus allowing a more efficient targeted delivery of anticancer agents while minimizing their distribution in healthy tissues. Graphene-based materials have been also investigated for the development of new imaging agents for the in vitro and in vivo diagnosis of several types of cancer as well as for the development of biosensors for the identification of specific cancer bio-markers. “Graphene-based materials for cancer therapy” aims at collecting full papers communications and reviews that prominently demonstrate the continuous efforts in developing advanced, graphene-based nanomaterials for cancer treatment and diagnosis. This Special Issue aims to cover a broad range of subjects, from nanomaterials synthesis to the design and development of nanostructures to be used as drug delivery systems, biosensors, and imaging agents for cancer treatment.
Prof. Daniela Iannazzo
Prof. Alessandro Pistone
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- graphene-based materials
- anticancer therapy
- drug delivery systems
- imaging agents